Ftse Mib
38.519,74
0,50%
DAX
22.785,39
-0,05%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
95.643,35
-0,14%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CytoSorbents Corporation (CTSO) CytoSorbents Corporation (CTSO) Notizie

CTSO

CytoSorbents (CTSO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CTSO
DataOraFonteTitoloSimboloCompagnia
01/02/202500:49Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CTSOCytoSorbents Corporation
23/01/202502:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
13/01/202515:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
13/01/202513:00GlobeNewswire Inc.CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights OfferingNASDAQ:CTSOCytoSorbents Corporation
06/01/202513:00GlobeNewswire Inc.CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in DubaiNASDAQ:CTSOCytoSorbents Corporation
03/01/202513:00GlobeNewswire Inc.CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product RevenueNASDAQ:CTSOCytoSorbents Corporation
23/12/202413:00GlobeNewswire Inc.CytoSorbents Rights Offering BeginsNASDAQ:CTSOCytoSorbents Corporation
12/12/202413:00GlobeNewswire Inc.CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference WeekNASDAQ:CTSOCytoSorbents Corporation
09/12/202413:18Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:CTSOCytoSorbents Corporation
09/12/202413:17Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CTSOCytoSorbents Corporation
09/12/202413:00GlobeNewswire Inc.CytoSorbents Announces Rights OfferingNASDAQ:CTSOCytoSorbents Corporation
26/11/202413:00GlobeNewswire Inc.CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CTSOCytoSorbents Corporation
11/11/202413:30GlobeNewswire Inc.CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in IndiaNASDAQ:CTSOCytoSorbents Corporation
07/11/202422:05GlobeNewswire Inc.CytoSorbents Reports Third Quarter 2024 Financial and Operational ResultsNASDAQ:CTSOCytoSorbents Corporation
04/11/202413:00GlobeNewswire Inc.CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP CertificationNASDAQ:CTSOCytoSorbents Corporation
22/10/202413:00GlobeNewswire Inc.FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive ReviewNASDAQ:CTSOCytoSorbents Corporation
17/10/202413:00GlobeNewswire Inc.CytoSorbents to Report Third Quarter 2024 Operating and Financial ResultsNASDAQ:CTSOCytoSorbents Corporation
01/10/202413:00GlobeNewswire Inc.CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business UpdateNASDAQ:CTSOCytoSorbents Corporation
01/10/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CTSOCytoSorbents Corporation
26/09/202423:05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:CTSOCytoSorbents Corporation
27/08/202413:00GlobeNewswire Inc.CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment ConferenceNASDAQ:CTSOCytoSorbents Corporation
17/08/202400:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
16/08/202423:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CTSOCytoSorbents Corporation
16/08/202422:05GlobeNewswire Inc.CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CTSOCytoSorbents Corporation
13/08/202422:19GlobeNewswire Inc.CytoSorbents Reports Second Quarter 2024 Financial and Operational ResultsNASDAQ:CTSOCytoSorbents Corporation
13/08/202422:18GlobeNewswire Inc.CytoSorbents Appoints Peter J. Mariani Chief Financial OfficerNASDAQ:CTSOCytoSorbents Corporation
13/08/202422:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTSOCytoSorbents Corporation
07/08/202413:00GlobeNewswire Inc.CytoSorbents to Report Second Quarter 2024 Operating and Financial ResultsNASDAQ:CTSOCytoSorbents Corporation
01/08/202413:00GlobeNewswire Inc.CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:CTSOCytoSorbents Corporation
29/07/202414:00GlobeNewswire Inc.CytoSorbents Unveils Newly Redesigned, Unified Company and Product WebsiteNASDAQ:CTSOCytoSorbents Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CTSO

La tua Cronologia

BIT
UC5LUF
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci